Login
  • About
  • Support
Menu
  • About
  • Support

Articles

Back to All Resources

Funakoshi Co., Ltd. joins our distributor network

March 7, 2020

490 BioTech is proud to announce that Funakoshi Co., Ltd. has joined our distributor network to serve our research clientele in Japan.

Read More »

490 BioTech receives NIH Phase II SBIR award for improving drug discovery screens and 3D microphysiological assays

September 21, 2019

490 BioTech is pleased to announce the acquisition of a Phase II SBIR award from the National Institutes of Health, National Institute of General Medical Sciences for the development of new high-throughput drug discovery screens

Read More »

490 BioTech partners with Applied StemCell for new regenerative medicine in vivo models

September 21, 2017

490 BioTech is pleased to announce a Phase II STTR award from the National Institutes of Health, National Institute of General Medical Sciences, that will enable the development of novel in vitro cellular and in

Read More »

490 BioTech releases COI policy

December 3, 2016

490 BioTech’s Conflict of Interest policy is available for public review at this LINK.

Read More »

New product distributors meeting our international customer needs

October 18, 2016

490 BioTech is pleased to announce distributor partnerships with Applied StemCell (USA, Japan), Proteigene (European Union, United Kingdom), and BioAspect Services About Applied StemCell: “Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered

Read More »

Funakoshi Co., Ltd. joins our distributor network

March 7, 2020

490 BioTech is proud to announce that Funakoshi Co., Ltd. has joined our distributor network to serve our research clientele in Japan.

Read More »

490 BioTech receives NIH Phase II SBIR award for improving drug discovery screens and 3D microphysiological assays

September 21, 2019

490 BioTech is pleased to announce the acquisition of a Phase II SBIR award from the National Institutes of Health, National Institute of General Medical Sciences for the development of new high-throughput drug discovery screens

Read More »

490 BioTech partners with Applied StemCell for new regenerative medicine in vivo models

September 21, 2017

490 BioTech is pleased to announce a Phase II STTR award from the National Institutes of Health, National Institute of General Medical Sciences, that will enable the development of novel in vitro cellular and in

Read More »

490 BioTech releases COI policy

December 3, 2016

490 BioTech’s Conflict of Interest policy is available for public review at this LINK.

Read More »

New product distributors meeting our international customer needs

October 18, 2016

490 BioTech is pleased to announce distributor partnerships with Applied StemCell (USA, Japan), Proteigene (European Union, United Kingdom), and BioAspect Services About Applied StemCell: “Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered

Read More »

Funakoshi Co., Ltd. joins our distributor network

March 7, 2020

490 BioTech is proud to announce that Funakoshi Co., Ltd. has joined our distributor network to serve our research clientele in Japan.

Read More »

490 BioTech receives NIH Phase II SBIR award for improving drug discovery screens and 3D microphysiological assays

September 21, 2019

490 BioTech is pleased to announce the acquisition of a Phase II SBIR award from the National Institutes of Health, National Institute of General Medical Sciences for the development of new high-throughput drug discovery screens

Read More »

490 BioTech partners with Applied StemCell for new regenerative medicine in vivo models

September 21, 2017

490 BioTech is pleased to announce a Phase II STTR award from the National Institutes of Health, National Institute of General Medical Sciences, that will enable the development of novel in vitro cellular and in

Read More »

490 BioTech releases COI policy

December 3, 2016

490 BioTech’s Conflict of Interest policy is available for public review at this LINK.

Read More »

New product distributors meeting our international customer needs

October 18, 2016

490 BioTech is pleased to announce distributor partnerships with Applied StemCell (USA, Japan), Proteigene (European Union, United Kingdom), and BioAspect Services About Applied StemCell: “Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered

Read More »
  • Product Guides
  • Articles
  • News & Events
Menu
  • Product Guides
  • Articles
  • News & Events
  • Home
  • About
  • Support
  • Login

490 BioTech, Inc.

2450 EJ Chapman Drive
Knoxville, Tennessee 37996, USA

Follow us on LinkedIn

Copyright 490 BioTech, Inc. 2023